Atlassian Corporation Plc (T1AM34)
B3 Stock Exchange · Brazil · prices in BRL · close of 27 Oct 2026
Key indicators
| Last close | BRL 58.38 |
|---|---|
| 52-week range | 14.26 – 61.17 |
| Return, 1 month / 3 months | +17.1% / +139.0% |
| Return, 1 year / 3 years | +31.5% / +33.3% |
| Trend | Uptrend |
| RSI (14) | 67 |
| Volatility (1 year) | 88.8% |
| Worst drawdown (1 year) | -69.4% |
| Average daily value traded | 0.11M BRL |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Atlassian Corporation Plc develops collaboration and productivity software used by software development, information technology and business teams. Its products include Jira for planning and tracking work, Confluence for shared documentation, Trello for organising tasks, and Bitbucket for code hosting, along with tools for service management and team communication. Customers range from small teams to large organisations across many industries. The company is headquartered in Sydney, Australia, and also maintains a substantial presence in the United States.
Atlassian Corporation Plc is represented on the B3 Stock Exchange in Brazil by a Brazilian depositary receipt (BDR) under the code T1AM34, with its price quoted in Brazilian reais (BRL). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Atlassian Corporation Plc (T1AM34) trades on the B3 Stock Exchange in Brazil. It last closed at BRL 58.38 on 27 October 2026.
Its price-based Market X-Ray is 62 out of 100 (a fair price profile), ranking 353 of 1,455 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 31.5% and over the last three months it rose 139.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on B3 Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 95 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 95.2% | ||
| From 52-week high | -2.1% | ||
| Momentum | 88 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 139.0% | ||
| 6-month return | 238.6% | ||
| 12-month return, skipping the last month | 12.3% | ||
| Stability (higher is calmer) | 7 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 88.8% | ||
| Worst drawdown, 1 year (smaller is calmer) | -69.4% | ||
| Liquidity | 59 · Fair | Moderate trading activity. | |
| Average daily value traded | 0.11M BRL | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | +5.9% |
|---|---|
| 1 month | +17.1% |
| 3 months | +139.0% |
| 6 months | +238.6% |
| 1 year | +31.5% |
| 3 years | +33.3% |
| 5 years | −49.2% |
Signals
| 50-day / 200-day average | 49.14 / 29.90 |
|---|---|
| Golden / death cross (60 days) | Golden, 42 days ago |
| New 52-week high | Yes |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.92 |
Technical summary
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on B3 Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.